glp 1 in perimenopause GLP-1 Microdosing for Perimenopause: Benefits & Risks Microdosing GLP-1 for Perimenopause: Why

5B, Supplementary Fig

Krass M, Volke A, Rnkorg K, Wegener G, Lund S, Abildgaard A, et al

NNC Rating 4.4 Trusted Compounding Pharmacies All-in monthly* $279/mo Coaching Minimal Lifestyle Support Insurance No Pros and Cons PROS Affordable compounded GLP-1s GLP-1 tablets or injections 24/7 expert support Money-back weight-loss guarantee All-inclusive pricing Fast process from intake to delivery Current promo $120 off your first month CONS Does not accept insurance Extremely expensive Ozempic No coaching or nutritional guidance Disorganized appointment system Price Transparency MEDVi has a simple pricing structure that includes your initial consultation, the cost of your medication, all necessary supplies, free shipping, unlimited messaging to your provider, and 24/7 support

He L, Feng D, Guo H, et al

Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year